Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
06/2003
06/10/2003US6576417 Synthetic antigens for the detection of antibodies to hepatitis C virus
06/10/2003CA2076652C Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase
06/05/2003WO2003046574A2 Complement c3 precursor biopolymer markers indicative of insulin resistance
06/05/2003WO2003046572A2 Biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046571A2 Hp and apolipoprotein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046570A2 Glycoprotein and apolipoprotein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046568A2 Protein biopolymer markers indicative of a disease state
06/05/2003WO2003046567A2 Protein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046565A2 Ig lambda biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046557A2 Hp biopolymer markers predictive of insulin resistance
06/05/2003WO2003046556A2 Globin biopolymer markers indicative of insulin resistance
06/05/2003WO2003046137A2 Hiv envelope v3-ccr5 binding site immunogen
06/05/2003WO2003046013A1 Fusion protein having enhanced in vivo activity of erythropoietin
06/05/2003WO2003046010A1 Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance
06/05/2003WO2003045993A2 Protein biopolymer markers predictive of type ii diabetes
06/05/2003WO2003045992A1 Cenp-e biopolymer marker indicative of age matched control
06/05/2003WO2003045984A2 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
06/05/2003WO2003045983A1 Apolipoprotein biopolymer markers predictive of type ii diabetes
06/05/2003WO2003045974A2 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003WO2003045973A2 Peptides with growth inhibitory action
06/05/2003WO2003045426A1 T-cell epitodes in carboxypeptidase g2
06/05/2003WO2002102835A8 Novel antimicrobial compounds
06/05/2003WO2002040510A3 Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors
06/05/2003US20030105300 Carbocyanine dyes/bioconjugates; optical tomography; fluorescence endoscopy; treating atherosclerotic plaques and blood clots; laser detection of metastasis
06/05/2003US20030105299 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications
06/05/2003US20030105292 Continously induced g-protein coupled receptors; membrane binding assays
06/05/2003US20030105286 Comprises pseudo-isocytosine and pseudo-uracil for increasing binding affinity to DNA/RNA strands
06/05/2003US20030105278 Melanin-concentrating hormone analogs
06/05/2003US20030105165 Gap junctions and EDHF
06/05/2003US20030105024 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
06/05/2003US20030105023 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
06/05/2003US20030105022 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
06/05/2003US20030105021 Using peptide comprising a chain of 7 to 17 contiguous amino acids derived from region of human TNF- alpha from Ser100 to Glu116 or from region of mouse TNF- alpha from Ser99 to Glu115 for manufacture of a medicament for oedema
06/05/2003US20030104992 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration
06/05/2003US20030104991 Didemnin analogs and fragments and methods of making and using them
06/05/2003US20030104622 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
06/05/2003US20030104589 Tissue adhesive using synthetic crosslinking
06/05/2003US20030104360 Synthetic receptors, libraries and uses thereof
06/05/2003US20030103993 HLA-DR2 binding peptides
06/05/2003US20030103990 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
06/05/2003CA2468501A1 T-cell epitodes in carboxypeptidase g2
06/05/2003CA2468187A1 Peptides with growth inhibitory action
06/05/2003CA2467892A1 Methods and compositions for derepression of iap-inhibited caspase
06/04/2003EP1316560A1 Novel human cancer/testis antigen and gene thereof
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315809A2 Control of crop pests and animal parasites through direct neuronal uptake
06/04/2003EP1315759A1 Purification process
06/04/2003EP1315750A2 Cyclic peptides having melanocortin-4 receptor agonist activity
06/04/2003EP1315739A2 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof
06/04/2003EP1315738A1 Extended native chemical ligation
06/04/2003EP1315517A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP0938496B1 Heptapeptide oxytocin analogues
06/04/2003EP0904098B1 Compositions comprising antifungal agent and acetate buffer
06/04/2003CN1422278A kahalalide F及相关化合物 kahalalide F and related compounds
06/04/2003CN1421461A Fusion protein with reinforced erythrocytin activity in vivo
06/04/2003CN1421456A Human apolipoprotein polypeptide and its use in resisting vascular proliferation diseases
06/04/2003CN1421244A Application of osteogenic growth peptide in promoting bematogenesis
06/04/2003CN1110556C Isolated nucleic acid molecules for coding tumor rejection antigen precursor MAGE-3 and use thereof
06/04/2003CN1110503C Isolated, truncated nucleicacid molecules of codeed GAGE tumor exclusion antigen
06/03/2003US6573363 Isolated polypeptide of given amino acid sequence; may be useful in the treatment of diseases characterized by overexpression of glycoprotein hormone; can use in diagnosis, treatment or prevention of cancer and diabetes
06/03/2003US6573244 Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins
06/03/2003US6573243 Pompilid wasp-derived neuropeptides
06/03/2003US6573242 Composition for activating macrophages comprising S-(2,3-dihydroxypropyl)-cysteine peptide having two fatty acids bonded as esters to dihydroxypropyl group and having specified amino acid sequence
06/03/2003US6573239 Compound comprising 15 to 26-residue peptide or peptide analogue which forms amphipathic alpha-helix in presence of lipids and exhibits specified lecithin:cholesterol acyltransferase activation activity
06/03/2003US6573084 Culture of Streptomyces anulatus 4811 (FERM BP-5808); deacylation of the lipid acyl moiety of FR-901379, Echinocandin B, and Aculeacin A
06/03/2003CA2145523C Polypeptides involved in streptogramineae biosynthesis; nucleotide sequences coding said polypeptides and their use
05/2003
05/30/2003WO2003044054A2 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases
05/30/2003WO2003044053A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/30/2003WO2003044046A1 Radamicine, a production method thereof and the use of same as an inducer of the tipa promotor
05/30/2003WO2003044045A2 Peptides promoting cell adherence, growth and secretion
05/30/2003WO2003043631A2 Method for identification of tumor targeting enzymes
05/30/2003WO2003001204A3 Type 1 diabetes diagnostics and therapeutics
05/30/2003WO2002076485A3 Vaccine for modulating between t1 and t2 immune responses
05/30/2003WO2002072621A3 Cyclohexapeptide having antimicrobial activity
05/30/2003WO2002064621A3 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
05/30/2003WO2002061114A3 Water-soluble, fluorescent and mobile peptide substrates
05/30/2003WO2002036160A3 Method for obtaining antigenic structures enhancing specific cross reactivity
05/30/2003CA2468170A1 Method for identification of tumor targeting enzymes
05/30/2003CA2467181A1 Peptides promoting cell adherence, growth and secretion
05/30/2003CA2467053A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/29/2003US20030100768 Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors
05/29/2003US20030100510 Crystallized structure of type IV collagen NC1 domain hexamer
05/29/2003US20030100508 Carbohydrate epitope mimic compounds and uses thereof
05/29/2003US20030100483 As preservatives; in prophylaxis and therapy of viral or microbial infection in animals and plants, and in inactivating endotoxin
05/29/2003US20030100090 Kinase mimic catalysts for asymmetric synthesis of phosphorylated insitols and cycloalkanols
05/29/2003US20030100076 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis
05/29/2003US20030100015 Protein biopolymer markers indicative of age matched control
05/29/2003US20030100014 Apolipoprotein biopolymer markers predictive of type II diabetes
05/29/2003US20030100013 HP biopolymer markers predictive of insulin resistance
05/29/2003US20030100011 IG lambda biopolymer markers predictive of alzheimers disease
05/29/2003US20030100009 Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance
05/29/2003US20030099611 Manipulation and detection of protein phosphatase 2c-pp2calpha - expression in tumor cells for cancer therapy, prevention and detection
05/28/2003EP1313756A1 Antibodies specific for methylated lysines in histones
05/28/2003EP1313754A1 Nucleophile-stable thioester generating compounds, methods of production and use
05/28/2003EP1313505A1 Hla binding peptides and their uses
05/28/2003EP1313440A1 Dental products comprising bone growth enhancing peptide
05/28/2003EP1106626B1 Process for the preparation of regular glycopeptides
1 ... 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 ... 423